ストックスクリーナーアプリを入手
1.53
0.66%
0.01
アフターアワーズ：
1.53
前日終値:
$1.52
開ける：
$1.5566
24時間の取引高:
3,317
Relative Volume:
0.17
時価総額：
$87.22M
収益：
$118.18M
当期純損益:
$5.99M
株価収益率:
11.60
EPS:
0.1319
ネットキャッシュフロー:
$-12.91M
1週間 パフォーマンス:
-4.38%
1か月 パフォーマンス:
+23.79%
6か月 パフォーマンス:
+16.79%
1年 パフォーマンス:
-50.49%
1日の値動き範囲:
$1.521
$1.5566
1週間の範囲:
$1.52
$1.6235
52週間の値動き範囲:
$1.17
$3.39
Intercure Ltd Stock (INCR) Company Profile
INCR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
INCR
Intercure Ltd
|
1.53 | 87.22M | 118.18M | 5.99M | -12.91M | 0.1319 |
|
ZTS
Zoetis Inc
|
160.41 | 66.72B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.45 | 48.08B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 47.74B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.48 | 18.49B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
308.07 | 13.31B | 2.76B | 1.11B | 898.10M | 22.77 |
Intercure Ltd Stock (INCR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-05-18 | アップグレード | Canaccord Genuity | Speculative Buy → Buy |
Intercure Ltd (INCR) 最新ニュース
InterCure (NASDAQ:INCR) Shares Down 4.4% – What’s Next? - Defense World
InterCure Reports FY2024 Results - mg Magazine
InterCure Reports Strong Start to 2025 Amid Recovery Efforts - TipRanks
InterCure Announces FY2024 Results and Provides Q1 2025 Update: Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million, Strong Start to 2025 - PR Newswire
Intercure Ltd. Delays Yearly Report Filing - TipRanks
Interbusiness, Virdis partner to distribute Intercure products - Rubber News
InterCure (NASDAQ:INCR) Stock Price Down 3.4% – Time to Sell? - Defense World
InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak - GuruFocus.com
InterCure (NASDAQ:INCR) Shares Down 0.7%What's Next? - MarketBeat
InterCure Announces Leadership Change and Secures $18.2 Million Financing - TipRanks
Short Interest in InterCure Ltd. (NASDAQ:INCR) Expands By 96.2% - MarketBeat
Jane Street Group LLC Acquires New Stake in InterCure Ltd. (NASDAQ:INCR) - Defense World
InterCure (NASDAQ:INCR) Trading Up 3.7% – Should You Buy? - Defense World
Cannabis co InterCure raising NIS 66m for Nir Oz facility - Globes
InterCure secures $18.2M for post-war recovery By Investing.com - Investing.com Australia
InterCure secures $18.2M for post-war recovery - Investing.com
InterCure Secures Major Funding to Boost Growth - TipRanks
InterCure has Secured Funding of NIS 66M to support the recovery of Nir Oz Facility - Nasdaq
Reviewing InterCure (NASDAQ:INCR) & NeuroBo Pharmaceuticals (NASDAQ:NRBO) - Defense World
InterCure Ltd. (NASDAQ:INCR) Short Interest Update - MarketBeat
InterCure Ltd. (NASDAQ:INCR) Sees Significant Drop in Short Interest - MarketBeat
Synbiotic's CAGR Forecast at 80%, ECS Botanics to Expand Footprint in Germany, & More from Intercure - Business of Cannabis -
Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company - Benzinga
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - Market Exclusive
InterCure nears break even in first half of 2024, despite ongoing Israel-Hamas war - Crain's Chicago Business
InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million - GlobeNewswire
InterCure Announces Expansion of its Strategic partnership with Cookies to Germany - Yahoo Finance
IM Cannabis Merger Scrapped, Cel AI Gets a New CEO, & More from Intercure - Business of Cannabis
Asset-Light Expansion Into $8B German Market Adds Potential To This Cannabis Stock On NASDAQ - Benzinga
Analyst: Israel’s InterCure paving path to big gains - Green Market Report
InterCure to Participate in Canaccord Genuity’s 8th Annual Global Cannabis Conference - Business Wire
InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million - Business Wire
InterCure: Bargain Israel Cannabis Play (NASDAQ:INCR) - Seeking Alpha
InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million - Business Wire
symbol__ Stock Quote Price and Forecast - CNN
InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint - Business Wire
InterCure advances restoration of Israeli site amid conflict By Investing.com - Investing.com India
InterCure Provides an Update Regarding Nir Oz Facility - GlobeNewswire
InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain - GlobeNewswire
InterCure Wins Cannolam Arbitration Proceeding - GlobeNewswire
Israeli Cannabis Firms Navigate Challenges Amid Hamas Conflict, Cellular Goods Signs New Joint Venture, & More from SEED Innovations - Business of Cannabis -
InterCure Ltd Issues Update Regarding the Security Situation in Israel By Investing.com - Investing.com UK
Israeli Cannabis Adjusts to War - Green Market Report
InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY - GlobeNewswire
InterCure votes to delist from the Toronto Stock Exchange - Mugglehead Magazine
Cookies launches flagship store in Austria with InterCure - Business of Cannabis
InterCure Informs That A Lawsuit Was Filed Against the Company by Minority Shareholders of Its Subsidiary - Stock Titan
InterCure to distribute Mike Tyson’s cannabis internationally - Mugglehead Magazine
InterCure Ltd. Partners with TYSON 2.0 in Israel, Australia, United Kingdom, Germany and Other EU Countries - GlobeNewswire
InterCure Delivers Rising Revenue, Positive Cash Flow - Green Market Report
InterCure Announces Record Fourth Quarter and Fiscal Year End 2022 Results - GlobeNewswire
Intercure Ltd (INCR) 財務データ
収益
当期純利益
現金流量
EPS
1.38%
1.22%
大文字化:
|
ボリューム (24 時間):